Company Filing History:
Years Active: 2004-2008
Title: Innovating Cancer Treatment: The Contributions of Mary K. Danks
Introduction
Mary K. Danks, a distinguished inventor based in Memphis, TN, has made significant strides in the field of cancer research. With a total of three patents to her name, Danks has focused her efforts on developing compositions and methods that enhance the efficacy of chemotherapeutic agents in treating human tumor cells. Her innovative work holds promise for improving cancer treatments, ultimately impacting patient care and outcomes.
Latest Patents
Danks's latest patents revolve around compositions and methods for sensitizing and inhibiting the growth of human tumor cells through novel approaches utilizing carboxylesterase enzymes. One of her key patents presents a framework for the metabolic activation of chemotherapeutic prodrugs, allowing the conversion of inactive metabolites into active drugs. This innovative technique not only enhances the effectiveness of the treatments but also opens avenues for identifying new drugs activated by this enzyme, thereby broadening the therapeutic landscape for cancer treatment.
Career Highlights
Mary K. Danks currently works at St. Jude Children's Research Hospital, an institution renowned for its commitment to advancing pediatric healthcare through groundbreaking research. Her work there encompasses the application of her patents to real-world cancer treatment challenges, showcasing her contributions to science and medicine.
Collaborations
Throughout her career, Danks has collaborated with esteemed colleagues, including Philip Michael Potter and Peter J. Houghton. These partnerships highlight the collaborative spirit of the scientific community, wherein shared knowledge and expertise foster innovative breakthroughs that can lead to impactful changes in treatment protocols.
Conclusion
Mary K. Danks exemplifies the spirit of innovation within cancer research. Her patents serve as a testament to her dedication to developing effective therapies for tumor cell sensitization and inhibition. As she continues her work at St. Jude Children's Research Hospital, her contributions will undoubtedly enhance the fight against cancer and improve the lives of many patients.